News
In response to President Trump’s February 13, 2025, Executive Order (EO) 14212, “Establishing The President’s Make America ...
York biotech company, the Aptamer Group has announced part two of a testing programme with Unilever. The deal sees Aptamer ...
Opinion
We got DOGE'd: Cuts to federal programs that fund innovation risk US world leadership long-termThe federal government’s role is not to chase quarterly returns. It is to invest in generational outcomes. Slashing investments for ideological reasons is shortsighted. And the damage may not be ...
3d
The Daily Galaxy on MSNFrom Trash to Power: New Enzyme Discovery Could Supercharge Global Biofuel ProductionA groundbreaking study published in Nature reveals a transformative enzyme that could revolutionize the production of ...
The natural protein, known as CelOCE, was developed at the Brazilian Center for Research in Energy and Materials and is ready ...
Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...
Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...
Fermbox Bio-ARC is a full-stack biotech product platform that spans concept-to-clone to large-scale manufacturing—powering a ...
In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results